Cardinal health announces progress on business and portfolio review and fiscal 2024 outlook update

Progress achieved on company's ongoing business and portfolio review completed review of growth businesses within the medical segment: investing in and further developing at-home solutions and optifreight® logistics as part of the company's portfolio for long-term growth and value creation review of global medical products and distribution business continues, with focus on driving operational performance through the medical improvement plan reorganizing leadership structure to continue company's simplification efforts, prioritize core operational execution and drive efficiencies, accountability and transparency updated enterprise operating and segment reporting structure, effective january 1, 2024, to be reflected in company's financial reporting beginning third quarter fiscal 2024 providing pro-forma long-term financial targets for updated segment reporting structure updated fiscal 2024 non-gaap diluted eps guidance to high end of $6.75 to $7.00 range primarily driven by favorability in interest and other and diluted weighted average shares outstanding, enabled by continued strong cash flow generation and incremental share repurchase during second quarter fiscal 2024 further updates and details to be provided on february 1 during fiscal 2024 q2 earnings call dublin, ohio , jan. 9, 2024 /prnewswire/ -- cardinal health (nyse:cah) today announced progress on the company's ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-gaap diluted earnings per share (eps) outlook. these updates build upon the company's momentum, focus on long-term value creation, and continued actions to become more streamlined and focused.
CAH Ratings Summary
CAH Quant Ranking